Nicotine pouches can be marketed as 'lower risk' than cigarettes. Is that dangerous?
The FDA has authorized Zyn to market its nicotine pouches as a lower-risk alternative to cigarettes, sparking debate among public health experts. While some argue it is a safer option for smokers trying to quit, others fear it could serve as a gateway to nicotine addiction for adolescents.
Why it matters
This decision represents a significant shift in tobacco regulation and public health strategy regarding harm reduction versus addiction prevention.
It comes in flavors like "Cool Mint," "Smooth," and "Chill." It's on the Ferrari F1 race car. And it's addictive.
A paperclip-sized pouch filled with bleach-white fibers and nicotine crystals placed between the lip and gum, leeches nicotine and other chemicals into the user's bloodstream — allowing anyone to use nicotine discreetly.
One of the most popular brands of nicotine pouches, Zyn, got a boost from the Food and Drug Administration recently. The FDA authorized the company to advertise: "Using Zyn instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis."
Bret Koplow, acting director of the FDA's Center for Tobacco Products, said in a press release that the decision "is intended to ensure that adult users have clear, science-based information about the relative harms of tobacco products, so they can make informed choices."
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in